Integrated serum pharmacochemistry, 16S rRNA sequencing and metabolomics to reveal the material basis and mechanism of Yinzhihuang granule against non-alcoholic fatty liver disease
Bibliographic Data
YZHG may treat NAFLD by improving the disruption of intestinal flora and enhancing the intestinal barrier. This will reduce the invasion of LPS into the liver subsequently regulate liver lipid metabolism and reduce liver inflammation
Bioinformatics · Biology · Disease · Fatty liver · Granule (geology · Gut flora · Lipid metabolism · Metabolomics · Sphingolipid · Alcohol Consumption and Health Effects · Chemistry · Liver Disease Diagnosis and Treatment · Medicine · Metabolomics and Mass Spectrometry Studies · Biochemistry · Internal Medicine · Pharmacology
Hemerocallis lilioasphodelus root water extract ameliorates non-alcoholic fatty liver disease by regulating the gut-liver axis and activating AMPK-mediated lipid metabolism
Miao medicine Jinshanxiaoke granules alleviates MASLD via Ampk/Ppar-α and Pi3k/Akt-mediated restoration of hepatic lipid homeostasis
Elucidating the anti-inflammatory material basis of the Tibetan medicine Tiebangchui by integrating UPLC-Q-Orbitrap MS, serum pharmacochemistry, and a zebrafish model
Huaganjian decoction ameliorates metabolic dysfunction-associated steatotic liver disease through liver-gut crosstalk
| Unique citing works | 4 |
|---|---|
| Citations per year | 4 |
| Citation span | 2025 - 2027 (3) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 3 |